Judaya, Carlito C.
HRN: 26-79-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/12/2025
03/20/2025
IV
2.25GM
Q8H
PNEUMONIA HIGH RISK
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes